Cargando…
Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242253/ https://www.ncbi.nlm.nih.gov/pubmed/37278129 http://dx.doi.org/10.1002/ctm2.1294 |
_version_ | 1785054177118912512 |
---|---|
author | Zhang, Da‐Wei Li, Fang Wei, Yuan‐Yuan Hu, Lei Chen, Su‐Hong Yang, Ming‐Ming Zhang, Wen‐Ting Fei, Guang‐He |
author_facet | Zhang, Da‐Wei Li, Fang Wei, Yuan‐Yuan Hu, Lei Chen, Su‐Hong Yang, Ming‐Ming Zhang, Wen‐Ting Fei, Guang‐He |
author_sort | Zhang, Da‐Wei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10242253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102422532023-06-07 Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19 Zhang, Da‐Wei Li, Fang Wei, Yuan‐Yuan Hu, Lei Chen, Su‐Hong Yang, Ming‐Ming Zhang, Wen‐Ting Fei, Guang‐He Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2023-06-05 /pmc/articles/PMC10242253/ /pubmed/37278129 http://dx.doi.org/10.1002/ctm2.1294 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Zhang, Da‐Wei Li, Fang Wei, Yuan‐Yuan Hu, Lei Chen, Su‐Hong Yang, Ming‐Ming Zhang, Wen‐Ting Fei, Guang‐He Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19 |
title | Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19 |
title_full | Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19 |
title_fullStr | Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19 |
title_full_unstemmed | Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19 |
title_short | Development and validation of a novel CD4(+) T cell‐related gene signature to detect severe COVID‐19 |
title_sort | development and validation of a novel cd4(+) t cell‐related gene signature to detect severe covid‐19 |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242253/ https://www.ncbi.nlm.nih.gov/pubmed/37278129 http://dx.doi.org/10.1002/ctm2.1294 |
work_keys_str_mv | AT zhangdawei developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19 AT lifang developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19 AT weiyuanyuan developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19 AT hulei developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19 AT chensuhong developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19 AT yangmingming developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19 AT zhangwenting developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19 AT feiguanghe developmentandvalidationofanovelcd4tcellrelatedgenesignaturetodetectseverecovid19 |